BACKGROUND: Although human red blood cell (RBC) units may be refrigerator stored for up to 42 days, transfusion of older RBCs acutely delivers a large bolus of iron to mononuclear phagocytes. Similarly, iron dextran circulates in plasma for hours to days and is progressively cleared by mononuclear phagocytes, which return iron to plasma. Finally, malaria infection continuously delivers iron to macrophages by intra- and extravascular hemolysis. Studies suggest that iron administration increases infectious risk. STUDY DESIGN AND METHODS: To assess the effects of increased iron availability on susceptibility to infection, we infected mice with model Gram-negative intracellular or extracellular pathogens (Salmonella typhimurium or Escherichia coli, respectively), accompanied by RBC transfusion, iron dextran administration, or malarial coinfection. RESULTS: In our mouse models, transfusion of older RBCs exacerbates infection with both Gram-negative pathogens. Although iron dextran exacerbates E. coli infection to a similar extent as transfusion of corresponding amounts of iron, higher iron doses are required to produce comparable effects with S. typhimurium. Coinfection of mice with Plasmodium yoelii and S. typhimurium produces overwhelming Salmonella sepsis. Finally, treating mice with antibiotics abrogates the enhancing effect on E. coli infection of both older RBC transfusion and iron dextran administration. CONCLUSIONS: Transfusion of older RBCs exacerbates Gram-negative infection to a similar extent as malaria coinfection or iron dextran administration. Appropriate antibiotic therapy abrogates the effect of older RBC transfusions on infection with E. coli. Iron delivery to macrophages may be an underappreciated mechanism mediating, at least some, adverse effects of RBC transfusions.
BACKGROUND: Although human red blood cell (RBC) units may be refrigerator stored for up to 42 days, transfusion of older RBCs acutely delivers a large bolus of iron to mononuclear phagocytes. Similarly, iron dextran circulates in plasma for hours to days and is progressively cleared by mononuclear phagocytes, which return iron to plasma. Finally, malaria infection continuously delivers iron to macrophages by intra- and extravascular hemolysis. Studies suggest that iron administration increases infectious risk. STUDY DESIGN AND METHODS: To assess the effects of increased iron availability on susceptibility to infection, we infected mice with model Gram-negative intracellular or extracellular pathogens (Salmonella typhimurium or Escherichia coli, respectively), accompanied by RBC transfusion, iron dextran administration, or malarial coinfection. RESULTS: In our mouse models, transfusion of older RBCs exacerbates infection with both Gram-negative pathogens. Although iron dextran exacerbates E. coli infection to a similar extent as transfusion of corresponding amounts of iron, higher iron doses are required to produce comparable effects with S. typhimurium. Coinfection of mice with Plasmodium yoelii and S. typhimurium produces overwhelming Salmonella sepsis. Finally, treating mice with antibiotics abrogates the enhancing effect on E. coli infection of both older RBC transfusion and iron dextran administration. CONCLUSIONS: Transfusion of older RBCs exacerbates Gram-negative infection to a similar extent as malaria coinfection or iron dextran administration. Appropriate antibiotic therapy abrogates the effect of older RBC transfusions on infection with E. coli. Iron delivery to macrophages may be an underappreciated mechanism mediating, at least some, adverse effects of RBC transfusions.
Authors: Paul A Carless; David A Henry; Jeffrey L Carson; Paul Pc Hebert; Brian McClelland; Katharine Ker Journal: Cochrane Database Syst Rev Date: 2010-10-06
Authors: Eldad A Hod; Ning Zhang; Set A Sokol; Boguslaw S Wojczyk; Richard O Francis; Daniel Ansaldi; Kevin P Francis; Phyllis Della-Latta; Susan Whittier; Sujit Sheth; Jeanne E Hendrickson; James C Zimring; Gary M Brittenham; Steven L Spitalnik Journal: Blood Date: 2010-03-18 Impact factor: 22.113
Authors: Rasmus Larsen; Raffaella Gozzelino; Viktória Jeney; László Tokaji; Fernando A Bozza; André M Japiassú; Dolores Bonaparte; Moisés Marinho Cavalcante; Angelo Chora; Ana Ferreira; Ivo Marguti; Sílvia Cardoso; Nuno Sepúlveda; Ann Smith; Miguel P Soares Journal: Sci Transl Med Date: 2010-09-29 Impact factor: 17.956
Authors: Christelle M Roux; Brian P Butler; Jennifer Y Chau; Tatiane A Paixao; Kong Wai Cheung; Renato L Santos; Shirley Luckhart; Renée M Tsolis Journal: Infect Immun Date: 2010-01-25 Impact factor: 3.441
Authors: Melanie E Fields; Monica L Hulbert; Ling Chen; Ari N Berlin; Ron Jackups; Philip C Spinella Journal: Transfusion Date: 2015-05-30 Impact factor: 3.157
Authors: Camilla L'Acqua; Sheila Bandyopadhyay; Richard O Francis; Donald J McMahon; Marianne Nellis; Sujit Sheth; Steven G Kernie; Gary M Brittenham; Steven L Spitalnik; Eldad A Hod Journal: Am J Hematol Date: 2015-10 Impact factor: 10.047
Authors: Irene Cortés-Puch; Kenneth E Remy; Steven B Solomon; Junfeng Sun; Dong Wang; Mariam Al-Hamad; Seth M Kelly; Derek Sinchar; Landon Bellavia; Tamir Kanias; Mark A Popovsky; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson Journal: Transfusion Date: 2015-09-07 Impact factor: 3.157
Authors: Francesca Rapido; Gary M Brittenham; Sheila Bandyopadhyay; Francesca La Carpia; Camilla L'Acqua; Donald J McMahon; Abdelhadi Rebbaa; Boguslaw S Wojczyk; Jane Netterwald; Hangli Wang; Joseph Schwartz; Andrew Eisenberger; Mark Soffing; Randy Yeh; Chaitanya Divgi; Yelena Z Ginzburg; Beth H Shaz; Sujit Sheth; Richard O Francis; Steven L Spitalnik; Eldad A Hod Journal: J Clin Invest Date: 2016-12-12 Impact factor: 14.808